KOMO Biosciences’ recent announcement of a research license agreement with Caravan Biologix for the KOMbine™ gene editing platform has received broad coverage across national biotech and financial news outlets.
Researchers at the University of Hawaii have developed advanced tools for significant genome modifications, which have now been licensed to a burgeoning startup, Komo Biosciences.
Researchers at the University of Hawaiʻi’s John A. Burns School of Medicine (JABSOM) have made a significant breakthrough in gene editing technology that could revolutionize how we treat genetic diseases.
University of Hawaii researchers publish non-nuclease next-generation precision genome engineering technology…
Scientists at the University of Hawaii have improved tools for making large changes to genomes and have licensed the technology to a new startup…
